Innovative Preparation of Biopharmaceuticals Using Transglycosylation Activity of Microbial Endoglycosidases
-
- Katoh Toshihiko
- Graduate School of Biostudies, Kyoto University
-
- Yamamoto Kenji
- Center for Innovative and Joint Research, Wakayama University
Search this article
Abstract
<p>Most functional biopharmaceuticals such as antibodies are glycoproteins carrying N-linked oligosaccharides (N-glycans). In animal cells, these glycans are generally expressed as heterogeneous glycoforms that are difficult to separate into a pure form. The structure of these glycans directly affects several biological aspects of the glycoproteins, especially binding affinity. Therefore, the preparation of glycoproteins with well-defined and homogeneous glycoforms is necessary for functional studies and improved efficacy, particularly for biopharmaceuticals. This review describes the recent remarkable progress in the development and production of biopharmaceutical glycan-modified antibodies, through the use of glycan remodeling using microbial endoglycosidases and sophisticated glycoengineering techniques utilizing microbial enzymatic reaction mechanisms.</p>
Journal
-
- Journal of Applied Glycoscience
-
Journal of Applied Glycoscience 68 (1), 1-9, 2021-03-11
The Japanese Society of Applied Glycoscience
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390005888481587968
-
- NII Article ID
- 130007996786
-
- ISSN
- 18807291
- 13447882
-
- HANDLE
- 2433/274028
-
- NDL BIB ID
- 031345528
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- IRDB
- NDL
- Crossref
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed